Reference health

Wharton’s Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance

https://doi.org/10.1155/2015/430847
CiteStamped reference-health badge
1 of 92 checkable references need attention · checked 2026-07-23

At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

References needing attention

marked retracted — notice via Crossref, record curated by Retraction Watch10.1186/scrt443
RETRACTED ARTICLE: Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling
The 91 checked references that resolve
resolves10.1089/107632701300062859
Multilineage Cells from Human Adipose Tissue: Implications for Cell-Based Therapies
resolves10.1177/000313489906500106
Cells Isolated from Adult Human Skeletal Muscle Capable of Differentiating into Multiple Mesodermal Phenotypes
resolves10.1038/sj.bmt.1705358
Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads
resolves10.1164/rccm.200607-941oc
Lung Cells from Neonates Show a Mesenchymal Stem Cell Phenotype
resolves10.1016/j.stem.2011.10.002
Adult Cardiac-Resident MSC-like Stem Cells with a Proepicardial Origin
resolves10.1167/iovs.11-8673
Mesenchymal Stem Cells in the Human Corneal Limbal Stroma
resolves10.1073/pnas.240309797
Postnatal human dental pulp stem cells (DPSCs) <i>in vitro</i> and <i>in</i> <i>vivo</i>
resolves10.1634/stemcells.22-5-649
Human Placenta‐Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential
resolves10.1016/j.fertnstert.2003.07.015
Lifetime expression of stem cell markers in the uterine endometrium
resolves10.1186/1471-213x-7-11
Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro
resolves10.1634/stemcells.2004-0013
Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord
resolves10.1016/j.mad.2007.12.002
Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies
resolves10.1016/j.bone.2003.07.005
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells,
resolves10.1038/srep07144
Aging disrupts cell subpopulation dynamics and diminishes the function of mesenchymal stem cells
resolves10.1089/scd.2013.0231
Age-Related Decreases of <i>Serum-Response Factor</i> Levels in Human Mesenchymal Stem Cells Are Involved in Skeletal Muscle Differentiation and Engraftment Capacity
resolves10.1002/stem.1709
Inhibition of Akt/mTOR Attenuates Age-Related Changes in Mesenchymal Stem Cells
resolves10.1164/rccm.201306-1043oc
Aging Mesenchymal Stem Cells Fail to Protect Because of Impaired Migration and Antiinflammatory Response
resolves10.3389/fnagi.2014.00103
SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin
resolves10.1007/s00109-011-0825-4
SIRT1 is required for long-term growth of human mesenchymal stem cells
resolves10.1016/j.scr.2011.11.002
Aging alters tissue resident mesenchymal stem cell properties
resolves10.1111/j.1365-2362.2010.02384.x
Age-dependent impairment of number and angiogenic potential of adipose tissue-derived progenitor cells
resolves10.1371/journal.pone.0111850
Aging Increases the Susceptivity of MSCs to Reactive Oxygen Species and Impairs Their Therapeutic Potency for Myocardial Infarction
resolves10.1089/rej.2009.0986
The Effect of Age on the Efficacy of Human Mesenchymal Stem Cell Transplantation after a Myocardial Infarction
resolves10.3109/14653240903313941
Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: limitations for autologous cell replacement strategies
resolves10.1042/CBI20090211
Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells
resolves10.1089/ten.tea.2012.0129
Effect of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs on Gene Expression of Mesenchymal Stem Cells
resolves10.1186/ar4614
Naproxen affects osteogenesis of human mesenchymal stem cells via regulation of Indian hedgehog signaling molecules
resolves10.1111/j.1582-4934.2010.01006.x
NSAIDS inhibit in vitro MSC chondrogenesis but not osteogenesis: implications for mechanism of bone formation inhibition in man
resolves10.4236/ojemd.2013.33027
High-Fat Diets-Induced Metabolic Alterations Alter the Differentiation Potential of Adipose Tissue-Derived Stem Cells
resolves10.1096/fj.10-171439
Obesity short‐circuits stemness gene network in human adipose multipotent stem cells
resolves10.1038/ijo.2012.171
Diet-induced obesity alters the differentiation potential of stem cells isolated from bone marrow, adipose tissue and infrapatellar fat pad: the effects of free fatty acids
resolves10.1007/s13770-013-0005-4
The adipogenic effect of palmitate in mouse bone marrow-derived mesenchymal stem cells
resolves10.1186/1471-2164-14-625
Stem cells isolated from adipose tissue of obese patients show changes in their transcriptomic profile that indicate loss in stemcellness and increased commitment to an adipocyte-like phenotype
resolves10.1126/science.1104342
How Obesity Causes Diabetes: Not a Tall Tale
resolves10.1900/rds.2009.6.260
Mesenchymal Stem Cells Derived from Bone Marrow of Diabetic Patients Portrait Unique Markers Influenced by the Diabetic Microenvironment
resolves10.1186/scrt468
Diabetes impairs the angiogenic potential of adipose-derived stem cells by selectively depleting cellular subpopulations
resolves10.1002/cbf.3056
Characterization of human adipose tissue‐derived stromal cells isolated from diabetic patient's distal limbs with critical ischemia
resolves10.1126/science.284.5411.143
Multilineage Potential of Adult Human Mesenchymal Stem Cells
resolves10.1016/j.tibtech.2006.01.010
Fat tissue: an underappreciated source of stem cells for biotechnology
resolves10.1634/stemcells.2005-0330
Human Umbilical Cord Matrix Stem Cells: Preliminary Characterization and Effect of Transplantation in a Rodent Model of Parkinson's Disease
resolves10.1186/scrt442
Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly
resolves10.1007/s11626-011-9480-x
Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton’s jelly
resolves10.1155/2013/428726
Comparison of Explant-Derived and Enzymatic Digestion-Derived MSCs and the Growth Factors from Wharton’s Jelly
resolves10.1634/stemcells.2006-0286
Biology of Stem Cells in Human Umbilical Cord Stroma: In Situ and In Vitro Surveys
resolves10.1016/s0091-679x(08)00006-x
Method to Isolate Mesenchymal‐Like Cells from Wharton's Jelly of Umbilical Cord
resolves10.1007/s10616-012-9528-0
Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods
resolves10.1016/j.placenta.2004.10.008
Wharton's jelly as a reservoir of peptide growth factors
resolves10.1006/bbrc.2001.5777
Retention of Multilineage Differentiation Potential of Mesenchymal Cells during Proliferation in Response to FGF
resolves10.1182/blood-2007-07-103697
PDGF, TGF-β, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and osteogenic lineages
resolves10.1002/jcp.20238
FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells
resolves10.4061/2011/235176
Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential
resolves10.1371/journal.pone.0110764
Umbilical Cord Wharton’s Jelly Repeated Culture System: A New Device and Method for Obtaining Abundant Mesenchymal Stem Cells for Bone Tissue Engineering
resolves10.1007/s10561-014-9425-1
Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton’s jelly matrix
resolves10.1007/s00418-008-0519-3
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers
resolves10.1089/scd.2010.0260
A Rapid, Simple, and Reproducible Method for the Isolation of Mesenchymal Stromal Cells from Wharton's Jelly Without Enzymatic Treatment
resolves10.1080/14653240600855905
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
resolves10.2174/1875043501104010006
Phenotype and Differentiation Potential of Stromal Populations Obtained from Various Zones of Human Umbilical Cord: An Overview
resolves10.1089/scd.2009.0299
New Emerging Potentials for Human Wharton’s Jelly Mesenchymal Stem Cells: Immunological Features and Hepatocyte-Like Differentiative Capacity
resolves10.2217/rme.09.12
Novel Sources of Fetal Stem Cells: Where do they Fit on the Developmental Continuum?
resolves10.1016/j.scr.2010.08.005
Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications
resolves10.1042/CBI20100326
Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method
resolves10.1007/s12015-010-9166-x
Human Wharton’s Jelly Stem Cells Have Unique Transcriptome Profiles Compared to Human Embryonic Stem Cells and Other Mesenchymal Stem Cells
resolves10.1038/sj.cgt.7701077
Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors
resolves10.3390/ijms140611692
Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications
resolves10.1002/jcb.24073
Human umbilical cord wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro
resolves10.1002/jcb.24724
Human Keloid Cell Characterization and Inhibition of Growth with Human Wharton's Jelly Stem Cell Extracts
resolves10.1371/journal.pone.0061366
Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In Vivo
resolves10.1007/s12015-014-9514-3
Human Wharton's Jelly Stem Cells, its Conditioned Medium and Cell-Free Lysate Inhibit the Growth of Human Lymphoma Cells
resolves10.1016/j.lungcan.2010.01.003
Human umbilical cord matrix-derived stem cells expressing interferon-β gene significantly attenuate bronchioloalveolar carcinoma xenografts in SCID mice
resolves10.3109/14653240903548194
Cytotherapy with naive rat umbilical cord matrix stem cells significantly attenuates growth of murine pancreatic cancer cells and increases survival in syngeneic mice
resolves10.1016/j.canlet.2009.02.011
Naïve human umbilical cord matrix derived stem cells significantly attenuate growth of human breast cancer cells in vitro and in vivo
resolves10.1002/jcb.24367
Human Wharton's Jelly stem cell conditioned medium and cell‐free lysate inhibit human osteosarcoma and mammary carcinoma cell growth in vitro and in xenograft mice
resolves10.1186/1471-2407-10-590
Therapy with un-engineered naïve rat umbilical cord matrix stem cells markedly inhibits growth of murine lung adenocarcinoma
resolves10.1158/0008-5472.CAN-08-2750
Rat Umbilical Cord Stem Cells Completely Abolish Rat Mammary Carcinomas with No Evidence of Metastasis or Recurrence 100 Days Post–Tumor Cell Inoculation
resolves10.1186/s12935-014-0093-9
Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice
resolves10.1371/journal.pone.0096836
Microvesicles Derived from Human Wharton's Jelly Mesenchymal Stem Cells Promote Human Renal Cancer Cell Growth and Aggressiveness through Induction of Hepatocyte Growth Factor
resolves10.1111/j.1365-2567.2008.02891.x
The immunomodulatory activity of human umbilical cord blood‐derived mesenchymal stem cells <i>in vitro</i>
resolves10.1016/j.cellimm.2011.09.010
Immunomodulatory effect of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on lymphocytes
resolves10.1634/stemcells.2007-1028
Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells
resolves10.2174/1875043501104010028
Wharton's Jelly Mesenchymal Stem Cells as Off-The-Shelf Cellular Therapeutics: A Closer Look into their Regenerative and Immunomodulatory Properties
resolves10.1038/cdd.2013.158
Immunobiology of mesenchymal stem cells
resolves10.1161/CIRCULATIONAHA.110.955971
Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair
resolves10.3727/096368908786092793
In Vivo Survival and Osteogenic Differentiation of Allogeneic Rat Bone Marrow Mesenchymal Stem Cells (MSCs)
resolves10.1016/j.cellimm.2012.06.010
Immune characterization of mesenchymal stem cells in human umbilical cord Wharton’s jelly and derived cartilage cells
resolves10.1016/j.expneurol.2004.06.023
Transplantation of pig stem cells into rat brain: proliferation during the first 8 weeks
resolves10.1507/endocrj.EJ12-0343
Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus
resolves10.1186/scrt446
A preliminary evaluation of efficacy and safety of Wharton’s jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus
resolves10.1002/jbmr.1851
DNA damage drives accelerated bone aging via an NF-<b>κ</b>B–dependent mechanism
resolves10.1186/1741-7015-11-146
Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells
resolves10.1186/ar4520
Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study
resolves10.1159/000362530
Mesenchymal Stromal Cells as an Adjuvant Treatment for Severe Late-Onset Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation
The 3 references without a DOI — listed, not checked
no DOI — not checked1
no DOI — not checked2
no DOI — not checked15
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1155/2015/430847"><img src="https://citestamp.com/citestamped/10.1155/2015/430847/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1155/2015/430847/badge.svg)](https://citestamp.com/citestamped/10.1155/2015/430847)